Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2018 | Flow cytometry vs. NGS testing for determining MRD negativity in patients with ALL

Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, Philadelphia, PA, speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, discusses the use of flow cytometry and NGS testing for determining MRD negativity in patients with acute lymphoblastic leukemia (ALL).